Evidence map›Paper›PMID 41210929›Full record

ArticleInterdisciplinary perspectives on infectious diseases2025

Prospects and Research Trends of Tuberculosis in Iran: A Bibliometric Study With a Science Mapping Approach.

Sadeghali Azimi, Bahareh Bashardoust, Masoud Mohammadi

Abstract read
In one paragraph

Article in Interdisciplinary perspectives on infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sadeghali AzimiDepartment of Infectious Diseases, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.ORCID https://orcid.org/0000-0002-1903-314X
Bahareh BashardoustDepartment of Medical Parasitology and Mycology, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran.ORCID https://orcid.org/0000-0002-0008-7367
Masoud MohammadiDepartment of Medical Information Sciences, School of Allied Medical Sciences, Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.ORCID https://orcid.org/0000-0001-9874-3045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tuberculosis (TB), as one of the challenges of the health system in Iran, is of interest to Iranian researchers. It is necessary to present the research perspective of the research in this field to guide the future research. The aim of this research is bibliometric and citation study and providing a scientific map of TB research in Iran. Methods: This bibliometric and cross-sectional analyzes the research outputs of the subject area of TB indexed in the Scopus database up to 2024. SciMAT and VOSviewer software were used to visualize and predict the trends in research on the topic. Results: The most scientific productions occurred in the years 2020-2022 as well as 2016, and the research density was low in these years. Isoniazid and rifampicin were the most frequent topics in TB researches. In terms of average citations, diabetes mellitus had the most citations. Multidrug-resistant TB, diseases and complications, signs and symptoms, diagnosis and epidemiology of TB, and immunological and genetic studies related to TB are three research lines in TB research. Conclusion: TB research in Iran is expanding both quantitatively and in terms of research concepts. Thematic maps and strategic diagrams were presented. Paying attention to themes and strategic diagrams in the research decision-making of TB researchers in Iran in order to conduct effective research is helpful. Also, subject specialists in various fields of TB can obtain a specific research perspective based on the maps and indicators provided.

Indexed as

bibliometricIrannetwork visualizationresearchscience mappingtuberculosis

Identifiers

PMID41210929
PMCPMC12595239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.